IGM Biosciences, Inc. Deferred Income, Noncurrent
IGM Biosciences, Inc. had Deferred Income, Noncurrent of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeNoncurrent · last filed 2025-07-31
- 2025-06-30: Deferred Income, Noncurrent $0.00.
- 2025-03-31: Deferred Income, Noncurrent $140.87M.
- 2024-12-31: Deferred Income, Noncurrent $141.47M.
- 2024-09-30: Deferred Income, Noncurrent $141.88M.
| Period end | Deferred Income, Noncurrent |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $140.87M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $141.47M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $141.88M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $143.05M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $142.65M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $143.02M 10-K · filed 2025-03-06 |
| 2023-09-30 | $142.54M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $143.22M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $144.81M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $146.19M 10-K · filed 2024-03-07 |
| 2022-09-30 | $144.55M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $146.12M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |